Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol
2024 · BMJ Open · 4 citations
https://doi.org/10.1136/bmjopen-2023-079863
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
5
Citations
1
h-index
0
i10-index
Dean O’Callaghan is an academic researcher from London Borough of Tower Hamlets. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Colorectal Cancer Screening and Detection & Metabolism, Diabetes, and Cancer. The author has an h-index of 1, co-authored 3 publications.
Click to start Chat